UT Health San Antonio Launches Clinical Trial to Study Rapamycin and Healthy Aging
March 26, 2026
March 26, 2026
SAN ANTONIO, Texas, March 26 -- The University of Texas Health San Antonio issued the following news release:
* * *
UT Health San Antonio launches clinical trial to study rapamycin and healthy aging
UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Agin . . .
* * *
UT Health San Antonio launches clinical trial to study rapamycin and healthy aging
UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Agin . . .